BioSpace News Archive

MetVital, Inc., a privately held biopharmaceutical company developing small molecule modulators of altered glutamate metabolism for the treatment of diseases with significant unmet medical need and commercial potential, today announces that the U.S. Food and Drug Administration (FDA) has notified MetVital that its lead drug candidate, “Anhydrous Enol-Oxaloacetate”

Antengene Corporation today announced its appointment of Zhinuan Yu, Ph.D., as Corporate Vice President (CVP) of Biometrics and Regulatory Enabling Functions

CF PharmTech, Inc. (“CF PharmTech”) announced today that it has raised US $50M in Series F financing following its US $90M Series E financing in January of 2020, in total, successfully completing an equity investment deal of nearly US $140M within six months.

AIVITA Biomedical, Inc., a private biotechnology company developing personalized vaccines for the treatment of cancer and prevention of COVID-19, announced that Hans Keirstead, Ph.D., chairman and chief executive officer, has been named to the “20 in 2020” by the Consulate General of Canada

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ( the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced the pricing of a public offering of 26,666,666 units at a price to the public of $0.45 per unit,

Zomedica Pharmaceuticals Corp. announced the pricing of its previously announced public offering of 187,500,000 common shares of the Company, together with short-term warrants to purchase up to 187,500,000 common shares, at a combined public offering price of $0.16 per share and accompanying warrant. Each common share is being sold in the offering together with one two-year warrant to purchase one common share at an exercise price of $0.16 per common share.

The Jason Foundation, Inc. launched a new statewide initiative to combat suicide deaths, Tennessee Won’t Be Silent.

Data suggests telehealth will remain despite many states reopening

Pager announced the appointment of two new members to the company’s Advisory Board, effective June 24, 2020. Joining the Advisory Board are Doug Blackwell, former Chief Information Officer of Horizon BlueCross BlueShield of NJ, and Dr.

CSRO Will Continue Efforts to Protect Patients, Workforce, and Economy